IP Library › Granted Patent US 12,303,899
Granted Patent B2
US 12,303,899 · App. 17/298,507 · Granted May 20, 2025

Systems and methods for on-chip analysis of nucleic acids and for multiplexed analysis of cells

Inventors: Harold G. Craighead (Ithaca, NY); Harvey C. Tian (Ithaca, NY); David M. Lin (Ithaca, NY); Adam J. Bisogni (Ithaca, NY)
Assignee: CORNELL UNIVERSITY
B01L3/502761C12Q1/6837B01L2200/0668B01L2300/0819B01L2300/0887B01L2300/123B01L2400/086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,303,899
App. No.
17/298,507
Granted
May 20, 2025
Kind
B2
Abstract

A microfluidic chip for on-chip detection of the presence or absence of a target nucleic acid region in an isolated nucleic acid sample is disclosed. The microfluidic chip includes a nucleic acid entanglement array, an isolated nucleic acid sample immobilized in the nucleic acid entanglement array, and at least one probe specific to a target nucleic acid region. Systems and methods of using the microfluidic chip are disclosed. An integrated microfluidic cell processing system is disclosed, which includes: a multiplexed microfluidic flow directing system having a plurality of reconfigurable microfluidic layers that form a plurality of reconfigurable microfluidic channels, where the multiplexed microfluidic flow directing system function to assist in directing flow of materials into, through, and out of the integrated cell processing system; and at least one microfluidic chip functionally integrated into at least one layer of the multiplexed microfluidic flow directing system, and operates under continuous flow conditions.

Claims (43)

1. An integrated microfluidic cell processing system comprising:

a flow directing system comprising a plurality of reconfigurable microfluidic layers that include:

an affinity microcolumn layer comprising a plurality of substantially vertical microcolumns passing therethrough and containing an affinity chromatography agent; and

at least one microfluidic chip functionally integrated into a layer below the affinity microcolumn layer, wherein said at least one microfluidic chip comprises a cell capture component and a nucleic acid entanglement component,

wherein the system operates under continuous flow conditions to process one or more cell.

2. The integrated microfluidic cell processing system according to claim 1 , wherein said cell capture component comprises a cell capture array comprising a plurality of cell capture micropillars, and wherein said nucleic acid entanglement component comprises a nucleic acid entanglement array comprising a plurality of nucleic acid entanglement micropillars.

3. The integrated microfluidic cell processing system according to claim 1 , wherein the at least one microfluidic chip is integrated with the flow directing system in a manner so that flow of materials into the flow directing system is directed into and through the at least one microfluidic chip before being exported from the flow directing system, and wherein the flow directing system is configured to: receive and export one or more sample in manual and/or automated fashion; and/or assist in sorting materials for export from the microfluidic system for further collection, purification, and/or analysis.

4. The integrated microfluidic cell processing system according to claim 1 , further comprising:

a top capping layer proximately disposed at a top surface of the affinity microcolumn layer and comprising a patterned grid having at least one opening in fluid alignment with at least one microcolumn so as to allow a sample liquid to pass through the top capping layer and into the at least one microcolumn;

a bottom capping layer beneath a bottom surface of the affinity microcolumn layer and comprising a parallel patterned grid of openings in fluid alignment with the microcolumns; and

a bottom frit gasket layer deposited between the bottom surface of the affinity microcolumn layer and the bottom capping layer for aiding the containment of the affinity chromatography agent.

5. The integrated microfluidic cell processing system according to claim 4 further comprising:

a top channel layer disposed between the top capping layer and the top surface of the microcolumn layer, wherein the top channel layer comprises a plurality of substantially horizontal channel portions each forming a flow channel fluidly connecting adjacent microcolumns of the microcolumns through which a single liquid sample is desired to pass in a serial manner, and wherein the top channel layer is optionally patterned to work in fluid and serial connection with the bottom capping layer so as to pass the single liquid sample through the microcolumns in a serial manner.

6. The integrated microfluidic cell processing system according to claim 4 further comprising:

a top port layer proximately disposed on the top capping layer, said top port layer comprising one or more input port each in fluidic alignment with a corresponding microcolumn so as to effectuate introduction of a sample liquid into a desired microcolumn.

7. The integrated microfluidic cell processing system according to claim 4 further comprising:

a bottom port layer proximately disposed on the bottom capping layer, said bottom port layer comprising one or more outlet port each in fluidic alignment with a corresponding microcolumn so as to effectuate expulsion of a liquid sample from a desired microcolumn.

8. The integrated microfluidic cell processing system according to claim 4 further comprising:

a top frit gasket layer for aiding the containment of the affinity chromatography agent, wherein said top frit gasket layer is deposited between the top surface of the microcolumn layer and the top capping layer.

9. The integrated microfluidic cell processing system according to claim 4 further comprising:

a top port layer proximately disposed on the top capping layer, said top port layer comprising one or more input port each in fluidic alignment with a corresponding microcolumn so as to effectuate introduction of a sample liquid into a desired microcolumn;

an optional bottom port layer proximately disposed on the bottom capping layer, said bottom port layer comprising one or more outlet port each in fluidic alignment with a corresponding microcolumn so as to effectuate expulsion of a liquid sample from a desired microcolumn; and

a top washer layer and/or a bottom washer layer for securing the ports of the top port layer and the optional bottom port layer in alignment with their corresponding microcolumns,

wherein said top washer layer is proximately deposited at the top capping layer and comprises a plurality of openings through which the ports of the top port layer protrude, and

wherein said bottom washer layer is proximately deposited at the bottom capping layer and comprises a plurality of openings through which the ports of the optional bottom port layer protrude.

10. The integrated microfluidic cell processing system according to claim 4 , wherein the affinity chromatography agent comprises an immobilized target molecule selected from the group consisting of a whole cell, a virus, a virus particle, a protein, a modified protein, a polypeptide, a modified polypeptide, an RNA molecule, a DNA molecule, a modified DNA molecule, a polysaccharide, an amino acid, an antibiotic, a pharmaceutical agent, an organic non-pharmaceutical agent, a macromolecular complex, a carbohydrate, a lipid, a small molecule, a chemical compound, a mixture of lysed cells, and a mixture of purified, partially purified, or non-purified protein, and optionally the immobilized target molecule is labeled and/or provided from a mixture of lysed cells, a mixture of purified, partially purified, or non-purified protein.

11. The integrated microfluidic cell processing system according to claim 1 , wherein said at least one microfluidic chip is configured for on-chip detection of a presence or absence of a target nucleic acid region in an isolated nucleic acid sample, wherein the nucleic acid entanglement component comprises a plurality of nucleic acid entanglement micropillars configured and arranged in a manner effective to physically entangle and maintain thereon an isolated nucleic acid sample; the at least one microfluidic chip further comprising:

the isolated nucleic acid sample immobilized in the nucleic acid entanglement array; and

at least one probe specific to a target nucleic acid region, said at least one probe being specifically bound to the target nucleic acid region and detectable when said isolated nucleic acid sample includes the target nucleic acid region,

thereby enabling on-chip analysis of the presence or absence of the target nucleic acid region in the isolated nucleic acid sample.

12. The integrated microfluidic cell processing system according to claim 11 , wherein the isolated nucleic acid sample comprises genomic DNA (gDNA), extrachromosomal DNA, chromatin, plasmid DNA, a nucleic acid aptamer, an oligonucleotide, or a nucleic acid biomarker and/or wherein the target nucleic acid region comprises a gene, mutation, or nucleotide sequence from a eukaryotic cell, a human or a non-human animal.

13. The integrated microfluidic cell processing system according to claim 11 , wherein the target nucleic acid region comprises a gene, mutation, or nucleotide sequence that is related to or that is a marker for presence or risk of a disease or abnormal condition of a multicellular organism; and/or wherein the target nucleic acid region is specific for a pathogen, antibiotic resistant strain of bacteria, food contaminant, foodborne illness, paternity determination, DNA fingerprinting, or individual identity.

14. The integrated microfluidic cell processing system according to claim 11 , wherein the at least one probe comprises a collection of multiple probes with each probe being specific to a unique target nucleic acid region or to another probe which is specific to a unique target nucleic acid region; and optionally the collection of multiple probes comprises a panel of probes effective to produce a genetic profile for a disease or abnormal condition in a multicellular organism.

15. The integrated microfluidic cell processing system according to claim 11 , wherein the at least one probe is a fluorescence probe or selected from the group consisting of molecular beacons, peptide nucleic acid probes, aptamers, and protein probes.

16. The integrated microfluidic cell processing system according to claim 1 , said system further comprising

a liquid collection apparatus comprising well portions for collecting liquid samples from the microcolumns, wherein each well portion is aligned with a single corresponding microcolumn for collection of the liquid sample therefrom.

17. The integrated microfluidic cell processing system according to claim 16 , wherein a liquid flow mechanism is programmable to move the liquid samples through the microcolumns at a desired flow rate, at a desired volume, for a desired amount of time, and/or for a desired time interval.

18. The integrated microfluidic cell processing system according to claim 16 , wherein a liquid flow mechanism comprises a pump for either pushing or pulling the liquid sample through one or more of the microcolumns.

19. The integrated microfluidic cell processing system according to claim 16 , wherein the liquid collection apparatus is a microplate having a plurality of wells for collecting liquid samples from the microcolumns.

20. A method of collecting one or more liquid sample, said method comprising:

providing an integrated microfluidic cell processing system according to claim 16 ;

running one or more liquid sample through the microcolumns of the affinity microcolumn layer of the system either in a parallel manner or a serial manner under conditions effective to allow a test agent contained in the liquid sample to bind specifically to a target molecule contained in the microcolumns; and

recovering from each microcolumn the test agent or test agents that bind specifically to the respective target molecules of each microcolumn, said recovering taking place in the liquid collection apparatus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2023
From: CRAIGHEAD, HAROLD G.; TIAN, HARVEY C.; LIN, DAVID M.; BISOGNI, ADAM J.
To: CORNELL UNIVERSITY
Reel/Frame 062378/0315 →
Continuity (3)
Provisional Application 62772618 · Nov 28, 2018
Provisional Application 62772620 · Nov 28, 2018
Related Publication 20220016629A1 · Jan 20, 2022
References Cited (80)
US 5304487A · Wilding et al. · 1994 [cited by applicant]
US 6696022B1 · Chan et al. · 2004 [cited by applicant]
US 6977148B2 · Dean et al. · 2005 [cited by applicant]
US 7384561B2 · Utsunomiya · 2008 [cited by applicant]
US 7964978B1 · Lee et al. · 2011 [cited by applicant]
US 8562918B2 · Jovanovich et al. · 2013 [cited by applicant]
US 8871446B2 · Hong et al. · 2014 [cited by applicant]
US 9086406B2 · Lee et al. · 2015 [cited by applicant]
US 9128091B2 · Toner et al. · 2015 [cited by applicant]
US 9250242B2 · Martin et al. · 2016 [cited by applicant]
US 9506845B2 · Fowler et al. · 2016 [cited by applicant]
US 9803192B2 · Craighead et al. · 2017 [cited by applicant]
US 9926552B2 · Craighead et al. · 2018 [cited by applicant]
US 20020081744A1 · Chan et al. · 2002 [cited by applicant]
US 20020125192A1 · Lopez et al. · 2002 [cited by applicant]
US 20030143599A1 · Makarov et al. · 2003 [cited by applicant]
US 20030162181A1 · Yang et al. · 2003 [cited by applicant]
US 20040050700A1 · Lopez-Canovas et al. · 2004 [cited by applicant]
US 20040053403A1 · Jedrzejewski et al. · 2004 [cited by applicant]
US 20040142491A1 · Indermuhle et al. · 2004 [cited by applicant]
US 20050019819A1 · Tooke et al. · 2005 [cited by applicant]
US 20050064575A1 · Belgrader et al. · 2005 [cited by applicant]
US 20050069459A1 · Ahn et al. · 2005 [cited by applicant]
US 20060133957A1 · Knapp et al. · 2006 [cited by applicant]
US 20070077547A1 · Shvets et al. · 2007 [cited by applicant]
US 20070218459A1 · Miller · 2007 [cited by examiner]
US 20080124721A1 · Fuchs et al. · 2008 [cited by applicant]
US 20080124779A1 · Oh et al. · 2008 [cited by applicant]
US 20080125330A1 · Cady et al. · 2008 [cited by applicant]
US 20080160602A1 · He et al. · 2008 [cited by applicant]
US 20080274905A1 · Greene · 2008 [cited by applicant]
US 20090098541A1 · Southern et al. · 2009 [cited by applicant]
US 20090186776A1 · Webb et al. · 2009 [cited by applicant]
US 20090191563A1 · Steemers et al. · 2009 [cited by applicant]
US 20100047924A1 · Webster et al. · 2010 [cited by applicant]
US 20100137163A1 · Link et al. · 2010 [cited by applicant]
US 20100190146A1 · Bynum et al. · 2010 [cited by applicant]
US 20110014605A1 · Stone · 2011 [cited by applicant]
US 20110027873A1 · Cho et al. · 2011 [cited by applicant]
US 20110212440A1 · Viovy et al. · 2011 [cited by applicant]
US 20110301058A1 · Cheng et al. · 2011 [cited by applicant]
US 20120091235A1 · Li et al. · 2012 [cited by applicant]
US 20140154703A1 · Skelley et al. · 2014 [cited by applicant]
US 20140193812A1 · Hamilton et al. · 2014 [cited by applicant]
US 20140194313A1 · Craighead et al. · 2014 [cited by applicant]
US 20150018226A1 · Hansen et al. · 2015 [cited by applicant]
US 20150099642A1 · Barany et al. · 2015 [cited by applicant]
US 20150166987A1 · Craighead et al. · 2015 [cited by applicant]
US 20170021353A1 · Jiao · 2017 [cited by examiner]
US 20180305682A1 · Craighead et al. · 2018 [cited by applicant]
EP 2714884A1 · 2014 [cited by applicant]
WO 2007050040A1 · 2007 [cited by applicant]
WO 2011017677A2 · 2011 [cited by applicant]
WO 2011017681A2 · 2011 [cited by applicant]
WO 2011038241A1 · 2011 [cited by applicant]
WO 2012162779A1 · 2012 [cited by applicant]
WO 2014153071A1 · 2014 [cited by applicant]
WO 2015077441A2 · 2015 [cited by applicant]
WO 2016154302A1 · 2016 [cited by applicant]
WO 2017004463A1 · 2017 [cited by applicant]
WO 2017205267A1 · 2017 [cited by applicant]
WO 2017205304A1 · 2017 [cited by applicant]
Petralia et al., “A novel miniaturized biofilter based on silicon micropillars for nucleic acid extraction”, 2017, Analyst, vol. 142, pp. 140-146 (Year: 2017). [cited by examiner]
Zhang et al., “Aptamers selected by cell-SELEX for application in cancer studies,” Bioanalysis, 2(5):907-918 (2010). [cited by applicant]
Dickey et al., “Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells,” Methods, 97:94-103 (2016). [cited by applicant]
Wan et al., “Capture, isolation and release of cancer cells with aptamer-functionalized glass bead array,” Lab Chip, 12:4693-4701 (2012). [cited by applicant]
Phillips et al., “Enrichment of Cancer Cells Using Aptamers Immobilized on a Microfluidic Channel,” Anal. Chem., 81:1033-1039 (2009). [cited by applicant]
Zheng et al., “Aptamer-Functionalized Barcode Particles for the Capture and Detection of Multiple Types of Circulating Tumor Cells,” Adv. Mater., 26:7333-7338 (2014). [cited by applicant]
Xu et al., “Aptamer-Based Microfluidic Device for Enrichment, Sorting, and Detection of Multiple Cancer Cells,” Anal. Chem., 81:7436-7442 (2009). [cited by applicant]
Sheng et al., “Aptamer-Enabled Efficient Isolation of Cancer Cells from Whole Blood Using a Microfluidic Device,” Anal. Chem., 84:4199-4206 (2012). [cited by applicant]
Shen et al., “Specific Capture and Release of Circulating Tumor Cells Using Aptamer-Modified Nanosubstrates,” Adv. Mater., 25:2368-2373 (2013). [cited by applicant]
Chen et al., “Targeted isolation and analysis of single tumor cells with aptamer-encoded microwell array on microfluidic device,” Lab Chip, 12:5180-5185 (2012). [cited by applicant]
Liu et al., “Rare cell chemiluminescence detection based on aptamer-specific capture in microfluidic channels,” Biosensors and Bioelectronics, 28:438-442 (2011). [cited by applicant]
Lin et al., “Assay of multiplex proteins from cell metabolism based on tunable aptamer and microchip electrophoresis,” Biosensors and Bioelectronics, 63:105-111 (2015). [cited by applicant]
Martin et al., “Capturing cancer cells using aptamer-immobilized square capillary channels,” Mol. BioSyst., 7:1720-1727 (2011). [cited by applicant]
Cabodi et al., “Entropic Recoil Separation of Long DNA Molecules,” Anal. Chem., 74:5169-5174 (2002). [cited by applicant]
Benitez et al., “Microfluidic Extraction, Stretching and Analysis of Human Chromosomal DNA from Single Cells,” Lab Chip, 12(22):4848-4854 (Nov. 21, 2012). [cited by applicant]
Saad et al., “Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291),” OncoTargets and Therapy, 10:1757-1766 (2017). [cited by applicant]
European Patent Office, Extended European Search Report issued in the counterpart European Application No. EP 1989162.7, dated Jul. 8, 2022. [cited by applicant]
International Searching Authority (USPTO), International Search Report and Written Opinion issued in counterpart PCT/US2019/063887, dated Apr. 8, 2020. [cited by applicant]